Submitted by Anonymous (not verified) on 20 November 2023 - 12:43
Human medicines European public assessment report (EPAR): Efavirenz/Emtricitabine/Tenofovir disoproxil Mylan, efavirenz,emtricitabine,tenofovir disoproxil, HIV Infections, Date of authorisation: 05/09/2017, Revision: 16, Status: Authorised
Source: